FI956014A - Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon - Google Patents

Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon Download PDF

Info

Publication number
FI956014A
FI956014A FI956014A FI956014A FI956014A FI 956014 A FI956014 A FI 956014A FI 956014 A FI956014 A FI 956014A FI 956014 A FI956014 A FI 956014A FI 956014 A FI956014 A FI 956014A
Authority
FI
Finland
Prior art keywords
pct
decapeptides
aids
treatment
medicament
Prior art date
Application number
FI956014A
Other languages
English (en)
Swedish (sv)
Other versions
FI956014A0 (fi
FI113008B (fi
Inventor
Juergen Engel
Bernhard Kutscher
Michael Bernd
Ulf Niemeyer
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of FI956014A0 publication Critical patent/FI956014A0/fi
Publication of FI956014A publication Critical patent/FI956014A/fi
Application granted granted Critical
Publication of FI113008B publication Critical patent/FI113008B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI956014A 1993-06-18 1995-12-14 Menetelmä terapeuttisesti käyttökelpoisten dekapeptidien valmistamiseksi FI113008B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4320201 1993-06-18
DE4320201A DE4320201A1 (de) 1993-06-18 1993-06-18 Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
EP9401037 1994-04-02
PCT/EP1994/001037 WO1995000168A1 (de) 1993-06-18 1994-04-02 Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids

Publications (3)

Publication Number Publication Date
FI956014A0 FI956014A0 (fi) 1995-12-14
FI956014A true FI956014A (fi) 1995-12-14
FI113008B FI113008B (fi) 2004-02-27

Family

ID=6490614

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956014A FI113008B (fi) 1993-06-18 1995-12-14 Menetelmä terapeuttisesti käyttökelpoisten dekapeptidien valmistamiseksi

Country Status (24)

Country Link
US (1) US5985834A (fi)
EP (1) EP0703786B1 (fi)
JP (1) JPH08511784A (fi)
KR (1) KR100352541B1 (fi)
CN (1) CN1136915C (fi)
AT (1) ATE213164T1 (fi)
AU (1) AU688315B2 (fi)
BR (1) BR9406893A (fi)
CZ (1) CZ285997B6 (fi)
DE (2) DE4320201A1 (fi)
DK (1) DK0703786T3 (fi)
ES (1) ES2172533T3 (fi)
FI (1) FI113008B (fi)
HU (1) HUT73673A (fi)
IL (1) IL110045A (fi)
NO (1) NO320945B1 (fi)
PL (1) PL175580B1 (fi)
PT (1) PT703786E (fi)
RU (1) RU2154492C2 (fi)
SG (1) SG52240A1 (fi)
TW (1) TW370532B (fi)
UA (1) UA41938C2 (fi)
WO (1) WO1995000168A1 (fi)
ZA (1) ZA944347B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5981489A (en) * 1996-07-18 1999-11-09 Alza Corporation Non-aqueous protic peptide formulations
US8962558B2 (en) 1997-07-04 2015-02-24 Johannes C. van Groeninghen Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3
DE19728737C1 (de) * 1997-07-04 1999-02-11 Johannes Christian Groeninghen Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten
AU2001260110B2 (en) * 1999-03-17 2005-05-05 Zentaris Gmbh Novel LHRH-antagonists, production and use thereof as medicament
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US20040138138A1 (en) * 2001-08-02 2004-07-15 Jurgen Engel Use of LHRH-antagonists in doses that do not cause castration for the improvement of T-cell mediated immunity
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US7250514B1 (en) * 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2009145690A1 (en) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
US9447152B2 (en) 2008-07-07 2016-09-20 Oxford Nanopore Technologies Limited Base-detecting pore
CN102245760A (zh) 2008-07-07 2011-11-16 牛津纳米孔技术有限公司 酶-孔构建体
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
JP2012516145A (ja) * 2009-01-30 2012-07-19 オックスフォード ナノポア テクノロジーズ リミテッド ハイブリダイゼーションリンカー
AU2010209528B2 (en) 2009-01-30 2015-10-01 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
KR101939420B1 (ko) 2011-02-11 2019-01-16 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 세공
IN2014DN00221A (fi) 2011-07-25 2015-06-05 Oxford Nanopore Tech Ltd
CN112646019B (zh) 2012-04-10 2022-08-16 牛津纳米孔科技公开有限公司 突变胞溶素孔
EP2875154B1 (en) 2012-07-19 2017-08-23 Oxford Nanopore Technologies Limited SSB method for characterising a nucleic acid
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
BR112015021788B1 (pt) 2013-03-08 2023-02-28 Oxford Nanopore Technologies Plc Métodos para mover uma ou mais helicases imobilizadas, para controlar o movimento de um polinucleotídeo alvo, para caracterizar um polinucleotídeo alvo e para controlar o carregamento de uma ou mais helicases em um polinucleotídeo alvo, uso de um poro de transmembrana e de um potencial aplicado e de um ou mais espaçadores, complexo, e, kit
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
EP3137490B1 (en) 2014-05-02 2021-01-27 Oxford Nanopore Technologies Limited Mutant pores
EP4053150A1 (en) 2014-09-01 2022-09-07 Vib Vzw Mutant csgg pores
US10266885B2 (en) 2014-10-07 2019-04-23 Oxford Nanopore Technologies Ltd. Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
CN105837674A (zh) * 2016-03-08 2016-08-10 无限极（中国）有限公司 一种东方铃蟾多肽及其制备方法与应用
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677193A (en) * 1985-02-22 1987-06-30 The Salk Institute For Biological Studies Peptides containing an aliphatic-aromatic ketone side chain
US5073624A (en) * 1985-04-09 1991-12-17 Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
WO1989009229A1 (en) * 1988-03-31 1989-10-05 Immunobiology Research Institute, Inc. Treatment of hiv viremic patients with thymopentin
HU208439B (en) * 1988-10-14 1993-10-28 Univ Tulane Process for producing pharmaceutical peptides
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
HU9503605D0 (en) 1996-02-28
TW370532B (en) 1999-09-21
ES2172533T3 (es) 2002-10-01
AU688315B2 (en) 1998-03-12
PT703786E (pt) 2002-07-31
BR9406893A (pt) 1996-09-10
FI956014A0 (fi) 1995-12-14
NO954996L (no) 1995-12-08
ATE213164T1 (de) 2002-02-15
HUT73673A (en) 1996-09-30
WO1995000168A1 (de) 1995-01-05
DE4320201A1 (de) 1995-01-12
KR960703015A (ko) 1996-06-19
RU2154492C2 (ru) 2000-08-20
UA41938C2 (uk) 2001-10-15
US5985834A (en) 1999-11-16
PL175580B1 (pl) 1999-01-29
SG52240A1 (en) 1998-09-28
DE59410052D1 (de) 2002-03-21
CN1125400A (zh) 1996-06-26
PL312219A1 (en) 1996-04-01
ZA944347B (en) 1995-02-15
IL110045A (en) 2000-06-01
NO320945B1 (no) 2006-02-20
DK0703786T3 (da) 2002-05-27
CZ285997B6 (cs) 1999-12-15
EP0703786B1 (de) 2002-02-13
CN1136915C (zh) 2004-02-04
EP0703786A1 (de) 1996-04-03
KR100352541B1 (ko) 2002-12-26
JPH08511784A (ja) 1996-12-10
IL110045A0 (en) 1994-10-07
FI113008B (fi) 2004-02-27
AU6564794A (en) 1995-01-17
NO954996D0 (no) 1995-12-08
CZ308995A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
AU684059B2 (en) Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
HK1068606A1 (en) Novel aminobenzoephenones
SE9802208D0 (sv) Novel compounds
AU3808795A (en) Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal product and their intended use in anticancer treatments
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
AU2811400A (en) Stable formulation containing fumagillin
HK1050203A1 (en) Novel fusidic acid derivatives.
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
AU2003298203A1 (en) Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
UA32315A (uk) Спосіб накладання шкірного шва
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns

Legal Events

Date Code Title Description
MA Patent expired